Visceral Obesity and Its Shared Role in Cancer and Cardiovascular Disease: A Scoping Review of the Pathophysiology and Pharmacological Treatments
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Visceral Obesity and Its Shared Role in Cancer and Cardiovascular Disease: A Scoping Review of the Pathophysiology and Pharmacological Treatments
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 23, Pages 9042
Publisher
MDPI AG
Online
2020-11-28
DOI
10.3390/ijms21239042
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of statin use on cancer-specific mortality and recurrence
- (2020) Jing Yang et al. MEDICINE
- Visfatin/eNampt induces endothelial dysfunction in vivo: a role for Toll-Like Receptor 4 and NLRP3 inflammasome
- (2020) Tania Romacho et al. Scientific Reports
- Visceral obesity and incident cancer and cardiovascular disease: An integrative review of the epidemiological evidence
- (2020) Erika Aparecida Silveira et al. Obesity Reviews
- Central body fatness is a stronger predictor of cancer risk than overall body size
- (2019) Amanda M. Barberio et al. Nature Communications
- Altered Adipose Tissue DNA Methylation Status in Metabolic Syndrome: Relationships Between Global DNA Methylation and Specific Methylation at Adipogenic, Lipid Metabolism and Inflammatory Candidate Genes and Metabolic Variables
- (2019) Daniel Castellano-Castillo et al. Journal of Clinical Medicine
- Management of Blood Cholesterol
- (2019) Francis J. Alenghat et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management
- (2019) Fei Luo et al. Cardiovascular Diabetology
- The Emerging Role of Adiponectin in Female Malignancies
- (2019) Luca Gelsomino et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications
- (2019) Michele Longo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adiponectin, Obesity, and Cancer: Clash of the Bigwigs in Health and Disease
- (2019) Sheetal Parida et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The role of visfatin in cancer proliferation, angiogenesis, metastasis, drug resistance and clinical prognosis
- (2019) Tsung-Chieh Lin Cancer Management and Research
- The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances
- (2019) Pouya Saraei et al. Cancer Management and Research
- Statins Reduce Epicardial Adipose Tissue Attenuation Independent of Lipid Lowering: A Potential Pleiotropic Effect
- (2019) Paolo Raggi et al. Journal of the American Heart Association
- The Potential Effect of Metformin on Cancer: An Umbrella Review
- (2019) Hong Yu et al. Frontiers in Endocrinology
- Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk
- (2019) Manuel F. Landecho et al. Nutrients
- Associations of serum fibroblast growth factor 23 levels with obesity and visceral fat accumulation
- (2018) Xiang Hu et al. CLINICAL NUTRITION
- Visfatin as marker of isolated coronary artery ectasia and its severity
- (2018) Haleh Ashraf et al. CYTOKINE
- Uncoupling effects of estrogen receptor α on LKB1/AMPK interaction upon adiponectin exposure in breast cancer
- (2018) Loredana Mauro et al. FASEB JOURNAL
- The Role of the Estrogen Pathway in the Tumor Microenvironment
- (2018) Natalie Rothenberger et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Thiazolidinediones and risk of colorectal cancer in patients with diabetes mellitus: A meta-analysis
- (2018) Ting-Ting Hu et al. Saudi Journal of Gastroenterology
- Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis
- (2018) Huaqing Yan et al. Cancer Management and Research
- The Relation of Obesity-Related Hormonal and Cytokine Levels With Multiple Myeloma and Non-Hodgkin Lymphoma
- (2018) H. Dean Hosgood et al. Frontiers in Oncology
- A role for FGF2 in visceral adiposity-associated mammary epithelial transformation
- (2018) Vanessa Benham et al. Adipocyte
- PPARs and Metabolic Disorders Associated with Challenged Adipose Tissue Plasticity
- (2018) Patricia Corrales et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Metformin: An Old Drug with New Applications
- (2018) Joseph Zhou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ezetimibe suppresses development of liver tumors by inhibiting angiogenesis in mice fed a high-fat diet
- (2018) Kouichi Miura et al. CANCER SCIENCE
- Fibroblast growth factor receptor is a mechanistic link between visceral adiposity and cancer
- (2017) D Chakraborty et al. ONCOGENE
- Metformin attenuates ER stress–induced mitochondrial dysfunction
- (2017) Qun Chen et al. Translational Research
- DNA methylation and DNA methyltransferases
- (2017) John R. Edwards et al. Epigenetics & Chromatin
- Genome-wide DNA promoter methylation and transcriptome analysis in human adipose tissue unravels novel candidate genes for obesity
- (2017) Maria Keller et al. Molecular Metabolism
- PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis
- (2017) Veronica Vella et al. Frontiers in Endocrinology
- Beneficial effects of metformin on energy metabolism and visceral fat volume through a possible mechanism of fatty acid oxidation in human subjects and rats
- (2017) Ichiro Tokubuchi et al. PLoS One
- Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes
- (2016) Nisa M. Maruthur et al. ANNALS OF INTERNAL MEDICINE
- Obesity, Inflammation, and Cancer
- (2016) Tuo Deng et al. Annual Review of Pathology-Mechanisms of Disease
- Statins in relation to adiponectin: A significant association with clinical implications
- (2016) Niki Katsiki et al. ATHEROSCLEROSIS
- Circulating Insulin-Like Growth Factor-1 Level and Ovarian Cancer Risk
- (2016) Yiyang Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Role of mitochondrial dysfunction in cancer progression
- (2016) Chia-Chi Hsu et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Visfatin stimulates endometrial cancer cell proliferation via activation of PI3K/Akt and MAPK/ERK1/2 signalling pathways
- (2016) Yingmei Wang et al. GYNECOLOGIC ONCOLOGY
- Statins Use and Risk of Breast Cancer Recurrence and Death: A Systematic Review and Meta-Analysis of Observational Studies
- (2016) Marjan Mansourian et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Evidence for Feedback Regulation Following Cholesterol Lowering Therapy in a Prostate Cancer Xenograft Model
- (2016) Elizabeth M. Masko et al. PROSTATE
- Cancer and inflammation
- (2016) Lance L. Munn Wiley Interdisciplinary Reviews-Systems Biology and Medicine
- Growth hormone replacement therapy reduces risk of cancer in adult with growth hormone deficiency: A meta-analysis
- (2016) Zhanzhan Li et al. Oncotarget
- Mutant KRas-Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions
- (2016) Geou-Yarh Liou et al. Cell Reports
- The Macrophage Switch in Obesity Development
- (2016) Angela Castoldi et al. Frontiers in Immunology
- Obesogenic memory can confer long-term increases in adipose tissue but not liver inflammation and insulin resistance after weight loss
- (2016) J. Schmitz et al. Molecular Metabolism
- Estrogen receptor-α drives adiponectin effects on cyclin D1 expression in breast cancer cells
- (2015) Loredana Mauro et al. FASEB JOURNAL
- Association Between Sex Hormones and Adiposity: Qualitative Differences in Women and Men in the Multi-Ethnic Study of Atherosclerosis
- (2015) Morgana L. Mongraw-Chaffin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bariatric and metabolic surgery: a shift in eligibility and success criteria
- (2015) Gema Frühbeck Nature Reviews Endocrinology
- The Role of the Mediators of Inflammation in Cancer Development
- (2015) José Veríssimo Fernandes et al. PATHOLOGY & ONCOLOGY RESEARCH
- Excess visceral adiposity induces alterations in mitochondrial function and energy metabolism in esophageal adenocarcinoma
- (2014) Niamh Lynam-Lennon et al. BMC CANCER
- Insulin-like growth factor-II: its role in metabolic and endocrine disease
- (2014) Callum Livingstone et al. CLINICAL ENDOCRINOLOGY
- Insulin Resistance, Diabetes, and Cardiovascular Risk
- (2014) Francesco Paneni et al. Current Atherosclerosis Reports
- Adipose tissue mitochondrial dysfunction triggers a lipodystrophic syndrome with insulin resistance, hepatosteatosis, and cardiovascular complications
- (2014) Cecile Vernochet et al. FASEB JOURNAL
- Association between growth hormone therapy and mortality, cancer and cardiovascular risk: Systematic review and meta-analysis
- (2014) Annalisa Deodati et al. GROWTH HORMONE & IGF RESEARCH
- New insights into IGF-1 signaling in the heart
- (2014) Rodrigo Troncoso et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Triple-negative breast cancer risk in women is defined by the defect of estrogen signaling: preventive and therapeutic implications
- (2014) Zsuzsanna Suba OncoTargets and Therapy
- Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials
- (2013) Matteo Monami et al. ACTA DIABETOLOGICA
- Statins are associated with reduced risk of gastric cancer: a systematic review and meta-analysis
- (2013) P. P. Singh et al. ANNALS OF ONCOLOGY
- Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies
- (2013) Yanqiong Liu et al. CANCER CAUSES & CONTROL
- Metformin Decreases Circulating Androgen and Estrogen Levels in Nondiabetic Women With Breast Cancer
- (2013) Carlo Campagnoli et al. Clinical Breast Cancer
- Statins Are Associated With Reduced Risk of Esophageal Cancer, Particularly in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis
- (2013) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Mechanism of the irreversible inhibition of human cyclooxygenase-1 by aspirin as predicted by QM/MM calculations
- (2013) L. Tóth et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Visfatin/Nampt: An Adipokine with Cardiovascular Impact
- (2013) Tania Romacho et al. MEDIATORS OF INFLAMMATION
- Cyclooxygenase inhibition improves endothelial vasomotor dysfunction of visceral adipose arterioles in human obesity
- (2013) Melissa G. Farb et al. Obesity
- Adiponectin and incident coronary heart disease and stroke. A systematic review and meta-analysis of prospective studies
- (2013) D. A. Kanhai et al. Obesity Reviews
- Pathophysiology of Human Visceral Obesity: An Update
- (2013) André Tchernof et al. PHYSIOLOGICAL REVIEWS
- Circulating Fibroblast Growth Factor 23 Is Associated with Angiographic Severity and Extent of Coronary Artery Disease
- (2013) Yunjun Xiao et al. PLoS One
- Link between obesity and cancer
- (2013) S. C. P. Williams PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pathophysiological roles of FGF signaling in the heart
- (2013) Nobuyuki Itoh et al. Frontiers in Physiology
- COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs
- (2013) Evrim Gurpinar et al. Frontiers in Oncology
- A preliminary study of the potential role of FGF-23 in coronary calcification in patients with suspected coronary artery disease
- (2012) Hirofumi Masai et al. ATHEROSCLEROSIS
- The Role of Adiponectin in Cancer: A Review of Current Evidence
- (2012) Maria Dalamaga et al. ENDOCRINE REVIEWS
- Effects of ezetimibe on visceral fat in the metabolic syndrome: a randomised controlled study
- (2012) Hiroyuki Takase et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Both Low and High Serum IGF-I Levels Associate with Cancer Mortality in Older Men
- (2012) Johan Svensson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals
- (2012) Joachim H. Ix et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- COX-2 Inhibitors and Cardiovascular Risk
- (2012) C. P. Cannon et al. SCIENCE
- LINE-1 methylation in visceral adipose tissue of severely obese individuals is associated with metabolic syndrome status and related phenotypes
- (2012) Valérie Turcot et al. Clinical Epigenetics
- Chronic Inflammation in Cancer Development
- (2012) Gabriele Multhoff et al. Frontiers in Immunology
- Visfatin exerts angiogenic effects on human umbilical vein endothelial cells through the mTOR signaling pathway
- (2011) Joo-Won Park et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Adiponectin induces growth inhibition and apoptosis in cervical cancer HeLa cells
- (2011) Lianying Xie et al. BIOLOGIA
- Inflammation and Increased Aromatase Expression Occur in the Breast Tissue of Obese Women with Breast Cancer
- (2011) Patrick G. Morris et al. Cancer Prevention Research
- Minireview: IGF, Insulin, and Cancer
- (2011) Emily J. Gallagher et al. ENDOCRINOLOGY
- Global Methylation in Exposure Biology and Translational Medical Science
- (2011) Heather H. Nelson et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Meta-Analysis and Dose-Response Metaregression: Circulating Insulin-Like Growth Factor I (IGF-I) and Mortality
- (2011) Anne Marij G. Burgers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Ambient Oxygen Promotes Tumorigenesis
- (2011) Ho Joong Sung et al. PLoS One
- Visceral obesity, metabolic syndrome, insulin resistance and cancer
- (2011) Suzanne L. Doyle et al. PROCEEDINGS OF THE NUTRITION SOCIETY
- Visceral adiposity, insulin resistance and cancer risk
- (2011) Claire L Donohoe et al. Diabetology & Metabolic Syndrome
- Rosiglitazone Revisited
- (2010) Steven E. Nissen et al. ARCHIVES OF INTERNAL MEDICINE
- Notch1 mediates visfatin-induced FGF-2 up-regulation and endothelial angiogenesis
- (2010) Yun-Hee Bae et al. CARDIOVASCULAR RESEARCH
- Biological role of matrix metalloproteinases: a critical balance
- (2010) S. Loffek et al. EUROPEAN RESPIRATORY JOURNAL
- The Relationship of Waist Circumference and BMI to Visceral, Subcutaneous, and Total Body Fat: Sex and Race Differences
- (2010) Sarah M. Camhi et al. Obesity
- Fibroblast Growth Factor 23: A Possible Cause of Left Ventricular Hypertrophy in Hemodialysis Patients
- (2009) Heng Jung Hsu et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Pharmacotherapy for obesity
- (2009) Mingfang Li et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
- (2009) F. Colotta et al. CARCINOGENESIS
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
- (2009) Orlando M. Gutiérrez et al. CIRCULATION
- The Role of Fibroblast Growth Factors in Tumor Growth
- (2009) M. Korc et al. CURRENT CANCER DRUG TARGETS
- Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-κB activation in endothelial cells
- (2008) Su-Ryun Kim et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Metformin: Effects on Micro and Macrovascular Complications in Type 2 Diabetes
- (2008) Clifford J. Bailey CARDIOVASCULAR DRUGS AND THERAPY
- Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide
- (2008) Pei Wang et al. CARDIOVASCULAR RESEARCH
- Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention
- (2008) Weidong Zhu et al. CLINICAL SCIENCE
- Basal lipolysis, not the degree of insulin resistance, differentiates large from small isolated adipocytes in high-fat fed mice
- (2008) S. Wueest et al. DIABETOLOGIA
- Growth Hormone Decreases Visceral Fat and Improves Cardiovascular Risk Markers in Women with Hypopituitarism: A Randomized, Placebo-Controlled Study
- (2008) Catherine Beauregard et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started